<?xml version="1.0" encoding="UTF-8"?>
<p>Over 85% of SARS-CoV-2 patients in China received TCM, which has been reviewed by Yang and colleagues.
 <xref rid="b100-dic-2020-4-15" ref-type="bibr">100</xref> The use of TCM was included in the Chinese National Treatment Guidelines for COVID-19 patients and was recommended for different stages and severity of disease (
 <xref rid="t2-dic-2020-4-15" ref-type="table">Table 2</xref>).
 <xref rid="b66-dic-2020-4-15" ref-type="bibr">66</xref> However, the effectiveness of TCM in treating COVID-19 patients still remains unclear. Well-designed, large-scale, randomised, double-blinded, and placebo-controlled studies are necessary to confirm the efficacy of TCM before making any recommendations on their use in the management of patients with COVID-19.
</p>
